Meza Soto, E.A. et al. 2025. The Role of GLP-1 Receptor Agonists (Ozempic and Mounjaro) as Secondary Therapy in Chronic Kidney Disease. Revista Científica Multidisciplinar SAGA. 2, 3 (Sep. 2025), 973–991. DOI:https://doi.org/10.63415/saga.v2i3.257.